Lipocine
LPCN
LPCN
42 hedge funds and large institutions have $21.9M invested in Lipocine in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
24% less capital invested
Capital invested by funds: $28.9M → $21.9M (-$6.96M)
40% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 20
Holders
42
Holding in Top 10
–
Calls
$1.4M
Puts
$801K
Top Buyers
| 1 | +$730K | |
| 2 | +$624K | |
| 3 | +$371K | |
| 4 |
ECM
Element Capital Management
New York
|
+$325K |
| 5 |
Goldman Sachs
New York
|
+$300K |
Top Sellers
| 1 | -$4.15M | |
| 2 | -$2.75M | |
| 3 | -$904K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$755K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$583K |